🇺🇸 FDA
Patent

US 6444695

Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors

expired A61KA61K31/353A61K31/4164

Quick answer

US patent 6444695 (Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors) held by The Regents of the University of California expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/353, A61K31/4164, A61K31/505, A61K31/7048